baber/WOPTO huggingface dataset:
Patent CA-2558204-A1 (CA)
Inventor: AUCLAIR JEAN-MICHEL
IPC: B65D5/48
Filed: 2005-03-04
Abstract: A carton having a dispensing feature adapted for permitting the removal of articles from within the carton (10). To erect the carton, a plurality of panels (54, 58, 62, 66) are connected together to define an end of the carton.  At least one removable portion (86) is provided in the erected carton and is defined by an endless tear line (88). The endless tear line includes multiple portions (88a, 88b, 88c, 88d) defined in the top wall, one side wall, and end flaps extending from the top wall (24) and the one side wall (20).
Patent CA-2560794-A1 (CA)
Title: Tankage system incorporating adsorption clarification and parallel plate separation
Inventor: ST GERMAIN DARIN L
IPC: B01D21/02
Filed: 2005-03-22
Abstract: A water treatment process and equipment for implementation of the process are provided. The equipment incorporates a high rate clarifier with series operated inclined parallel plate settlers, followed by adsorption clarification with buoyant media.
Patent CA-2562504-A1 (CA)
Inventor: COBB NOEL C
IPC: B26B3/06
Filed: 2005-04-08
Abstract: A utility knife for glaziers and sheet rock workers has a two-part handle. The handle clamps a detachable reversible knife blade at a transverse angulated position with respect thereto. Vertical cuts can be made in tight corners without applying excessive force. The transversely angulated knife blade affords access permitting vertical cuts in tight corners. During cutting the user's hands are displaced from the cutting line, and kept from being inline with the cutting blades, thereby preventing injury.
Patent CA-2565082-A1 (CA)
Inventor: ADAMS CHRISTOPHER
IPC: G10D3/14
Filed: 2005-01-19
Abstract: The invention relates to a device and method for automatic tuning of a string instrument (1), in particular, a guitar, comprising a recording device (12), for recording a tone generated by striking a string (6a - 6f) and for the output of a digital signal corresponding to the recorded tone, a memory device for storage of given digital signals which correspond to a desired tone, a comparator device for comparison of the digital signal output by the recording device (12) with a digital signal corresponding to the desired tone stored in the memory device, an adjuster device for altering the tension of the strings (6a 6f), at least one actuator (11), for operating the adjuster device (7), a controller (10) connected to the comparator device, which controls the at least one actuator (11) using a bus line, by means of a difference determined in the comparator device between the signals representing the generated tone and the desired tone. The above is improved with relation to conventional techniques in so far as the above may be integrated in an instrument, in particular, a guitar, with minimal effect on the sound properties and with the smallest and least possible number of elements. The controller (10) and the at least one actuator (11) are arranged in the string instrument (1), on opposing sides of the strings (6a - 6f) viewed in the longitudinal direction of the strings (6a - 6f) and a string (6a - 6f), made from a conducting material or wound or coated with such, is used as bus line between the controller (10) and the at least one actuator. Furthermore, a method for the automatic tuning of a string instrument (1) is disclosed.
Patent CA-2566824-A1 (CA)
Title: Improved electrochemical cell
Inventor: MAXWELL IAN ANDREW
IPC: G01F23/02
Filed: 1998-03-25
Abstract: The invention relates to an amperometric electrochemical cell having a first insulating substrate carrying a first electrode, a second insulating substrate carrying a second electrode, said electrodes being disposed to face each other and spaced apart by less than 500 µm, and defining a sample reservoir therebetween, and wherein at least one, and preferably both, insulating substrates and the electrode carried thereon include an electromagnetic radiation transmissive portion in registration with said reservoir. The walls of the electrochemical cell may be formed from a thin metallic portion on a transparent substrate. Such cells are useful in providing visual confirmation of the validity of the electrochemical measurement.
Patent CA-2566929-A1 (CA)
Title: Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery
Inventor: EDWIN TARUN J
IPC: A61F2/90
Filed: 1995-09-15
Abstract: A radially expandable stent-graft and method of making the same, including at least one stent member encapsulated between at least two longitudinally expanded polytetrafluoroethylene (ePTFE) coverings. The at least one stent member (22) has openings through watt surfaces of the stent to permit radial expansion. The at least two longitudinally expanded ePTFE coverings (24,26) are circumferentially applied over the at least one stent member in their unsintered state, and sintered during application of a circumferential pressure to bond the ePTFE around and through the wall surfaces of the stent (22). The sintered ePTFE forms a substantially continuous, monolithic and integral encapsulation of the at least one stent. Upon radial expansion of the stent graft (10), the stent and the ePTFE node-fibril microstructure radially deform. Radial deformation of the ePTFE encapsulation results in nodal elongation in the axis of radial expansion. After radial expansion of the stent-graft (10), a substantial bonded area remains intact and maintains the encapsulation of the stent in vivo.
Patent CA-2567121-A1 (CA)
Inventor: BOATMAN DONN NATHAN
IPC: D21F11/00
Filed: 2005-05-23
Abstract: The present invention relates to an apparatus for producing a deep-nested embossed paper product comprising two embossing cylinders (100, 200), each cylinder having a plurality of protrusions (110, 210) on its surface. The protrusions on each cylinder are disposed in a non-random pattern where the respective non-random patterns are coordinated to each other. The two embossing cylinders are aligned such that the respective coordinated non-random pattern of protrusions nest together such that the protrusions engage each other to a depth of greater than about 1.016 mm. The protrusions each comprise a top plane (130, 230) and sidewalls (140, 240), with the top plane and sidewalls meeting at a protrusion corner (150, 250). The protrusion corners of the protrusions of the embossing cylinders of the apparatus of the present invention have a radius of curvature ranging from about 0.076 mm to about 1.778 mm.
Patent CA-2569085-A1 (CA)
Inventor: UBALIJORO ELIANE
IPC: C12P19/34
Filed: 2005-05-09
Abstract: Polynucleotide primers and probes for the specific amplification and detection of E. coli in samples are provided. The polynucleotide primers and probes are targeted to the E. coli prpP and/or ykgM genes and can detect a wide range of E. coli strains. The primers and probes can be used in real time diagnostic assays for rapid detection of E. coli in a variety of situations and are capable of distinguishing E. coli from Shigella spp. Kits comprising the primers and probes are also provided.
Patent CA-2569806-A1 (CA)
Title: Soft handoff for reverse link in a wireless communication system with frequency reuse
Inventor: TEAGUE EDWARD HARRISON
IPC: H04B1/713
Filed: 2005-06-08
Abstract: For soft handoff on the reverse link with restrictive reuse, a wireless terminal searches for pilots transmitted by sectors in a wireless system, measures the detected pilots, selects a serving sector (e.g., the strongest received sector), and identifies non-serving sectors that may receive high interference from the terminal. The serving sector assigns the terminal with subband(s) that are usable by the serving sector and unusable by the non-serving sectors. The terminal transmits data symbols on the assigned subbands to the serving and non-serving sectors. These sectors process the reverse link transmission from the terminal and obtain soft-decision symbols, which are estimates of the transmitted data symbols. The soft-decision symbols from co-located sectors may be combined and then decoded to obtain decoded packets.  The sectors may also independently decode the soft-decision symbols, and the decoded packets from these sectors may be combined to obtain final decoded packets for the terminal.
Patent CA-2573758-A1 (CA)
Inventor: HENRY KEVIN M
IPC: A61K31/74
Filed: 2005-07-07
Abstract: Bis-quaternary ammonium salts of formula (I), wherein Y is a group of formula NR11R12 +X- or NR7; n is 0 or 1; p is 1 or 2; r and q are independently 2, 3 or 4; X is an anionic counterion and R1R2R3N- and R4R5R6N- are independently selected from groups of formula-N(R13)2R8, N(R14)3,-N(R13)3, -N(R13)2(CH2)qOC(O)R9, and formula (a), wherein R7, R11 and R12 are independently selected from C1-C18 alkyl; R8,R9, R10 and R15 are independently selected from C8-C18 alkyl and C8-C18 alkenyl; R13 is C1-C4 alkyl; R14 is C2-C4 hydroxyalkyl; and R11 is selected from C2-C4 hydroxyalkyl, C2-C4aminoalkyl and groups of formula -(CH2)rNHC(O)R15 are effective inhibitors of corrosion and biofouling of metallic surfaces in contact with gas- and oil-field fluids.
Patent CA-2574206-A1 (CA)
Title: Phenothiazine derivatives and their method of use
Inventor: DUTTA APURBA
IPC: C07D279/18
Filed: 2005-06-24
Abstract: Novel phenothiazine derivatives and their use in the treatment of diabetes mellitus (type I and type II), and as an ovulation inhibitor (contraceptive), cancer chemotherapeutic and/or prophylactic agent, anti-obesity drug (body weight regulator), and immunostimulant.
Patent CA-2574268-A1 (CA)
Inventor: WANG HUA
IPC: B32B27/08
Filed: 2005-07-13
Abstract: A multilayer thermoformable film comprises (A) a top-layer thermoplastic film having an inner surface and an outer surface, where the top layer thermoplastic film has a softening temperature, (B) at least one mask layer thermoplastic film, where the mask layer thermoplastic film has a softening temperature that is within about 30 degrees centigrade of the softening temperature of the top layer film, and (C) at least one tielayer disposed between the inner surface of the top layer film and the mask layer.
Patent CA-2578411-A1 (CA)
Inventor: KAMATA MASAHIRO
IPC: G01V13/00
Filed: 2005-08-15
Abstract: Various techniques are described which may be used to facilitate and improve seismic exploration activities. For example, one aspect of the present invention is directed to a technique for enabling in-situ measurement of geophone response parameters. Another aspect of the present invention is directed to a technique for improving geophone calibration and for improving the accuracy of measurement of geophone response parameters. Yet another aspect of the present invention is directed to a technique for compensating geophone response output data in order to improve the accuracy of such data.
Patent CA-2581410-A1 (CA)
Title: Temporary dental prosthesis
Inventor: LAST-POLLAK MORDEHAI
IPC: A61C13/107
Filed: 2005-09-15
Abstract: A temporary prosthesis for use during the osseointegration process of an installed dental implant comprises load-absorbing properties and is mountable to the implant, providing an aesthetic appearance to the implant site, while preventing or minimizing loads on the implant itself.
Patent CA-2581758-A1 (CA)
Title: Method and apparatus for treating cheyne-stokes respiration
Inventor: KANE MICHAEL T
IPC: A61M16/00
Filed: 2005-09-29
Abstract: A system and method for delivering a flow of breathing gas to an airway of a patient. The system monitors a characteristic that varies based on variations of the flow of the breathing gas and determines a Target Flow for the gas to be delivered to the patient based on the monitored characteristic. The Target Flow is set to a level sufficient to treat Cheyne-Stokes respiration or a sleep disordered breathing event. The system also alters the Target Flow based on a determination that the patient is experiencing a sleep disordered breathing event. In a further embodiment, the system determines an apnea detection time (Tapnea) as Tinspplus a constant, and delivers a machine triggered breath if an amount since the start of inspiration reaches Tapnea.  Yet another embodiment, monitors the characteristic during an inspiratory phase of a respiratory cycle, and controls the flow of gas during the inspiratory phase of the respiratory cycle based on a result of this comparison.
Patent CA-2582470-A1 (CA)
Inventor: BIBETTE JEROME
IPC: B01J19/00
Filed: 2005-10-12
Abstract: The invention describes a method for the synthesis of compounds comprising the steps of: (a) compartmentalising two or more sets of primary compounds into microcapsules; such that a proportion of the microcapsules contains two or more compounds; and (b) forming secondary compounds in the microcapsules by chemical reactions between primary compounds from different sets; wherein one or both of steps (a) and (b) is performed under microfluidic control;  preferably electronic microfluid.ic control The invention further allows for the identification of compounds which bind to a target component of a biochemical system or modulate the activity of the target, and which is co~-compartmentalised into the microcapsules.
Patent CA-2582701-A1 (CA)
Inventor: LATORSE MARIE-PASCALE
IPC: A01N43/828
Filed: 1997-12-02
Abstract: 1) Compositions fongicides comprenant un composé (I) qui est la (4-S) 4-méthyl-2-méthylthio-4-phényl-1-phénylamino-2-imidazoline-5-one et un composé  (II) choisi dans le groupe comprenant : (IIA) le propamocarbe ; (IIB) le S-méthyl ester de l'acide 1,2,3-benzothiadiazole-7-carbothioïque, de formule :      - (IIC) le cyprodinil ; - (IID) l'acide 2-hydroxy-benzoïque ou acide salicylique, ses esters et ses sels, notamment de métaux alcalins et alcalino-terreux ; - le composé (IIF) ou 8-t-butyl-2-(N-ethyl-N-n-propylamino)-methyl-1,4-dioxaspiro[4.5]decane, encore appelé spiroxamine ; - le composé (IIG) ou ester isopropylique de l'acide [2-méthyl-1-(1-p-tolyl-éthylcarbamoyl)-propyl], encore appelé fencaramide ; - le composé (IIH) ou 4-chloro-2-cyano-1-dimethylsulfamoyl-5-(4-methylphenyl)imidazole ; le rapport composé (I)/composé (II) étant compris entre 0,01 et 50, de préférence entre 0,1 et 10.   2) Procédé de lutte, à titre curatif ou préventif, contre les champignons phytopathogènes des cultures, caractérisé en ce que l'on applique sur les parties aériennes des végétaux une quantité efficace et non phytotoxique d'une de ces compositions fongicides.
Patent CA-2584808-A1 (CA)
Title: Substituted pyridines with activity on syk kinase
Inventor: ARGADE ANKUSH
IPC: C07D401/04
Filed: 2005-10-31
Abstract: The present invention is directed to substituted pyridines, methods for their preparation and methods for their use in the treatment and/or prevention of mast cell related conditions.
Patent CA-2585176-A1 (CA)
Title: Ion source with substantially planar design
Inventor: LUTEN HENRY A
IPC: H01J27/14
Filed: 2005-11-07
Abstract: In certain example embodiments of this invention, there is provide an ion source including an anode and a cathode. In certain example embodiments, the cathode does not overhang over the anode, or vice versa. Since no, or fewer, areas of overhang are provided between the anode and cathode, there is less undesirable build-up on the anode and/or cathode during operation of the ion source so that the source can run more efficiently. Moreover, in certain example embodiments, an insulator such as a ceramic or the like is provided between the anode and cathode.
Patent CA-2585576-A1 (CA)
Title: Method for treating hiv infection through co-administration of tipranavir and darunavir
Inventor: KRAFT MICHAEL FRIEDRICH
IPC: A61K31/34
Filed: 2005-11-14
Abstract: A method for treating HIV infection through co-administration of tipranavir and darunavir.
Patent CA-2587087-A1 (CA)
Inventor: BUNICK FRANK J
IPC: A61K9/00
Filed: 2005-10-26
Abstract: The present invention provides an edible dosage form that incorporates optical elements (e.g., printed patterns, microrelief gratings, and/or macrorelief gratings), capable of producing unique optical effects and images in order to enable a user to better identify and differentiate the dosage forms, as well as to improve the detection of counterfeit production thereof, wherein the edible dosage forms may be made in a variety of ways to incorporate the optical elements therein.
Patent CA-2587238-A1 (CA)
Inventor: MCKAY IAN
IPC: C08F4/02
Filed: 2007-05-02
Abstract: The use of high activity "Single Site" polymerization catalysts often causes the fouling of polymerization reactors. The problem is particularly acute with gas phase polymerizations. While not wishing to be bound by theory it is believed that the fouling is initiated by the buildup of static charges in the reactor. The use of anti-static agents mitigates this problem, but typical antistatic agents contain polar species, which can deactivate the polymerization catalyst. We have now discovered that the use of a porous metal oxide support allows large levels of a selected antistatic agent to be used in a manner that reduces static/fouling problems in highly active polymerization catalysts.
Patent CA-2587684-A1 (CA)
Inventor: HILL IRMA P
IPC: A61B5/296
Filed: 2005-11-14
Abstract: A catheter adapted for mapping near a tubular region of a heart, has an elongated tubular catheter body having proximal and distal ends, an intermediate section distal of the catheter body, and a mapping assembly at the distal end of the intermediate section. The electrode-carrying mapping assembly has a generally circular main segment with a support member having shape-memory, and a generally linear proximal segment which has greater flexibility than either the intermediate section or the generally circular main segment. The generally circular main segment is adapted to releasably anchor itself in the tubular region and to map circumferentially around the tubular region and the generally linear segment is adapted to contact generally along its length heart wall tissue near an ostium of the tubular region.
Patent CA-2588412-A1 (CA)
Title: 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses
Inventor: DELUCA HECTOR F
IPC: A61P11/06
Filed: 2005-11-18
Abstract: This invention discloses 2.alpha.-methyl-19-nor-vitamin D analogs, and specifically 2.alpha.-methyl-19-nor-1.alpha.-hydroxy-homopregnacalciferol and pharmaceutical uses therefor. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also has little, if any, calcemic activity and therefore may be used to treat autoimmune disorders or inflammatory diseases in humans as well as renal osteodystrophy. This compound may also be used for the treatment or prevention of obesity.
Patent CA-2590297-A1 (CA)
Title: Procede de decoration d'un article et equipement pour la mise en oeuvre de ce procede
Inventor: CLAVEAU JEAN-NOEL
IPC: B41M5/035
Filed: 2005-12-13
Abstract: La présente invention concerne un procédé de décoration d'un article comportant une étape de préparation d'une feuille de transfert en ouate de cellulose par impression avec au moins une encre thermoactivable, une étape de transfert par application de ladite feuille sur l'article à décorer, et par chauffage de cet ensemble caractérisé en ce que le chauffage est réalisé par trempage de l'article à décorer associé à la feuille de transfert dans un bain d'alliage de métaux non ferreux maintenu à une température nominale pour l'activation de l'encre thermoactivable. Elle concerne également un équipement pour la mise en AEuvre de ce procédé.
Patent CA-2592023-A1 (CA)
Inventor: BRUDER FRIEDRICH-KARL
IPC: G11B7/246
Filed: 2005-12-09
Abstract: The invention relates to a substrate material, characterised in that a charged region on the surface of the corresponding moulding piece with voltages of -1.5 to +1.5 kV, the proportion of the total surface of which is between 95 and 100 %, charged regions with voltages of -1.5 to -2.5 or +1.5 to +2.5, the proportion of which is 0 to 5 % and charged regions of <-2.5 kV or >+2.5 kV, the proportion of which is up to 1 % of the total surface of the disc are provided, whereby the potential measurement is achieved by means of a Monroe probe at a distance of 3.5 mm from the substrate surface, the scanning region measures 12 cm in both the X- and Y-direction and potentials are measured at each 2 mm in the X- and in the Y-direction.
Patent CA-2596750-A1 (CA)
Title: Cross-linked polyethylene having excellent inhibition of sweat-out and insulation properties
Inventor: SONG YOUNGIL
IPC: H01B3/42
Filed: 2006-11-22
Abstract: The present invention relates to a cross-linked polyethylene composition having outstanding sweat-out inhibition and insulation properties. The composition of the invention characteristically comprises (A) 100 weight part of polyethylene; (B) 0.2 - 0.6 weight part of a mixture of a liquid antioxidant and a hindered phenol or thio ester antioxidant; (C) 0.2 - 0.9 weight part of polyethylene glycol having a molecular weight of 5,000 - 70,000; and (D) 1 - 4 weight part of a cross-linking agent.
Patent CA-2598122-A1 (CA)
Title: Method for making dense material
Inventor: PETERSON JOHN ROGER
IPC: F42B12/72
Filed: 2006-01-26
Abstract: A composition having high density and low toxicity suitable for use as a shotgun pellet, a bullet or armor piercing projectile and a method for manufacturing such composition is described. This material and product are developed to economically address the toxicity problems inherent in lead shot and bullets. This composition, in its present embodiment, is also suitable for use in any product requiring high-density and low toxicity. One present embodiment maintains the magnetic properties of the projectile if desired.
Patent CA-2601394-A1 (CA)
Title: Immunogens for vaccines against antigenically variable pathogens and diseases
Inventor: MANUCHARYAN KAREN
IPC: C07K5/00
Filed: 2006-03-17
Abstract: The present invention provides compositions and methods for the therapeutic and/or prophylactic treatment of pathogen infections and/or disease states.  The compositions may comprise variable epitope libraries (VELs), containing antigenic epitopes with one or more amino acid substitutions in the native epitope sequence. In preferred embodiments, the substituted amino acid may be replaced with each of the 19 other naturally occurring amino acids. In more preferred embodiments, multiple amino acid residues may be substituted. Such compositions and methods may be of use for production of vaccines against pathogens or diseases that show a high degree of genetic variability.
Patent CA-2604813-A1 (CA)
Inventor: CRONER DIANE M
IPC: A61L12/14
Filed: 2006-04-06
Abstract: A buffering system having a pKa which may be selected based on the environment in which the solution is designed to be used. Solutions containing the buffering system according to the present invention include borate-polyol complexes as the primary buffering agents, and may include one or more of the following: an aqueous liquid medium; an antimicrobial component; a surfactant component; a viscosity-inducing component; and/or a tonicity component. The borate-polyol buffering system may be formulated to have a lower pKa than traditional systems.
Patent CA-2606334-A1 (CA)
Inventor: FOX BRIAN A
IPC: C07K14/705
Filed: 2006-05-12
Abstract: La présente invention concerne des polypeptides co-récepteurs de pHHLA2 et des fragments et des anticorps fonctionnels desdits polypeptides, des polynucléotides isolés les encodant, des vecteurs contenant les polynucléotides, des cellules contenant les vecteurs. L'invention concerne également des procédés de fabrication et d'utilisation de ces molécules co-réceptrices de pHHLA2 co-stimulantes.